 Fresh off a big deal, what’s Aman’s outlook?

What’s changing in Indian pharma, Namita?

What can be done better in backing startups?

What drove growth and what should change next?

Will innovation drive the next pharma leap

Is deal pressure slowing Torrent innovation?

Does pharma need a mindset shift for R&D?

What’s missing in low-cost pharma innovation?

Have bold pharma bets delivered desired scale?

Was the Amplitude deal a bold adjacency bet?

Can policy push pharma innovation ahead?

Is lower US dependence a safer pharma bet?

Are women in pharma getting their due now?

Is China pulling far ahead in the pharma race?

What key lessons did Namita learn from dad?

Do you prefer continuity or disrupt style

Conclusion

Credits

India’s pharma sector is at a turning point transitioning from a global generics powerhouse to a serious contender in biotech and innovation. In this episode, host Vikas Dandekar is joined by Namita Thapar, Executive Director, Emcure Pharmaceuticals, Aman Mehta, Managing Director, Torrent Pharma, and Sharvil Patel, Managing Director, Zydus Lifesciences to explore what it takes to climb the innovation ladder. From regulatory roadblocks and pricing pressures to building a robust R&D ecosystem, the panel lays it all out. Patel reflects on Zydus’ early bet on research, Thapar shares Emcure’s commitment to women’s health and inclusive leadership, while Mehta highlights the shift toward patient-first thinking. Blending sharp insights, real-world data, and candid personal stories, this conversation asks the big question: Can India go from being the “pharmacy of the world” to becoming its “laboratory”?

You can follow Vikas Dandekar on his social media: Twitter and Linkedin and read her Newspaper Articles.

Listen to the first installment of Corner Office Conversation called Corner Office Conversation with Pawan Goenka, Chairman, IN-SPACe

Catch the latest episode of the new show “Corner Office Conversation” on: Spotify, Amazon Music, Apple Podcasts,and wherever you get your podcasts from.

India&rsquo;s pharma sector is at a turning point transitioning from a global generics powerhouse to a serious contender in biotech and innovation. In this episode, host Vikas Dandekar is joined by Namita Thapar, Executive Director, Emcure Pharmaceuticals, Aman Mehta, Managing Director, Torrent Pharma, and Sharvil Patel, Managing Director, Zydus Lifesciences to explore what it takes to climb the innovation ladder. From regulatory roadblocks and pricing pressures to building a robust R&amp;D ecosystem, the panel lays it all out. Patel reflects on Zydus&rsquo; early bet on research, Thapar shares Emcure&rsquo;s commitment to women&rsquo;s health and inclusive leadership, while Mehta highlights the shift toward patient-first thinking. Blending sharp insights, real-world data, and candid personal stories, this conversation asks the big question: Can India go from being the &ldquo;pharmacy of the world&rdquo; to becoming its &ldquo;laboratory&rdquo;? You can follow Vikas Dandekar on his social media: <a href="https://twitter.com/VikasReports">Twitter</a> and <a href="https://www.linkedin.com/in/vikas-dandekar-2a0a619">Linkedin</a> and read her <a href="https://economictimes.indiatimes.com/etreporter/author-vikas-dandekar-479242213.cms?from=mdr">Newspaper Articles</a>. Listen to the first installment of Corner Office Conversation called <a href="https://podcasts.apple.com/in/podcast/corner-office-conversation-with-pawan-goenka-chairman/id1827451035?i=1000718205446">Corner Office Conversation with Pawan Goenka, Chairman, IN-SPACe </a>Catch the latest episode of the new show &ldquo;Corner Office Conversation&rdquo; on: <a href="https://open.spotify.com/show/4fq4hKHPZO3MVDNhtOQ5OU?si=99e033dfb01a44c7">Spotify</a>, <a href="https://music.amazon.com/podcasts/1f0c9fc5-f702-4a84-bd7d-4f010bea72a5/corner-office-conversation">Amazon Music</a>, <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777">Apple Podcasts</a>,and wherever you get your podcasts from.

Corner Office Conversation is The Economic Times’ flagship interview podcast featuring unfiltered, one-on-one conversations with some of India and the world’s most powerful business leaders.

Hosted by ET’s top journalists and editors, this fortnightly show goes beyond headlines and press releases to explore how CEOs and founders think, decide, and lead in an era of disruption.

From Marc Benioff (Salesforce), Dara Khosrowshahi (Uber), and Roland Busch (Siemens) to Adar Poonawalla (Serum Institute), Suresh Narayanan (Nestlé India), and Ravi Kumar S (Cognizant), these conversations uncover personal leadership playbooks, global strategy pivots, lessons from failures, and bold visions for the future — across industries like tech, healthcare, manufacturing, finance, and consumer goods.

New episodes drop every alternate Monday.

Corner Office Conversation is The Economic Times&rsquo; flagship interview podcast featuring unfiltered, one-on-one conversations with some of India and the world&rsquo;s most powerful business leaders.
Hosted by ET&rsquo;s top journalists and editors, this fortnightly show goes beyond headlines and press releases to explore how CEOs and founders think, decide, and lead in an era of disruption.
From Marc Benioff (Salesforce), Dara Khosrowshahi (Uber), and Roland Busch (Siemens) to Adar Poonawalla (Serum Institute), Suresh Narayanan (Nestl&eacute; India), and Ravi Kumar S (Cognizant), these conversations uncover personal leadership playbooks, global strategy pivots, lessons from failures, and bold visions for the future &mdash; across industries like tech, healthcare, manufacturing, finance, and consumer goods.
New episodes drop every alternate Monday.

Corner Office Conversation

Corner Office Conversation with The New Leaders of Indian Pharma